1. The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer

4. Targeted Therapies Used in the Treatment of Patients With mCRC

6. Case 1: 70-year-old Man With Inoperable mCRC (cont)

9. Ziv-aflibercept: Potential Side Effects

11. Ziv-aflibercept: Monitoring for Side Effects

13. Case 2: 47-year-old Woman With Disease Recurrence Following an Initial Diagnosis of Stage IIIC Colon Cancer

18. Regorafenib: Key Patient Education Issues

19. Regorafinib: Potential Side Effects

20. Case 2: 47-year-old Woman With mCRC Receiving Regorafenib

21. Regorafinib: Monitoring for Side Effects

22. Hand-Foot Skin Reaction

23. Strategies for Combating Fatigue

24. The Importance of Patient Education

25. Strategies for Prevention and Treatment of HFSR

26. Hand-Foot Skin Reaction (cont)

27. Hand-Foot Syndrome vs Hand-Foot Skin Reaction

28. Summary: Strategies for Optimizing Use of New Targeted Agents in mCRC

29. Abbreviations

30. References

31. References (cont)

32. References (cont)